Last10K.com

Aethlon Medical Inc (AEMD) SEC Filing 8-K Material Event for the period ending Wednesday, March 23, 2022

Aethlon Medical Inc

HISTORY TOOLS
CIK: 882291 Ticker: AEMD

View differences made from one to another to evaluate Aethlon Medical Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Aethlon Medical Inc.

Continue

Assess how Aethlon Medical Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Aethlon Medical Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Cover
Ticker: AEMD
CIK: 882291
Form Type: 8-K Corporate News
Accession Number: 0001683168-22-001956
Submitted to the SEC: Mon Mar 28 2022 9:15:13 AM EST
Accepted by the SEC: Mon Mar 28 2022
Period: Wednesday, March 23, 2022
Industry: Laboratory Analytical Instruments
Events:
  1. Event for Officers

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/aemd/0001683168-22-001956.htm